Author:
Balinsky Corey A.,Jiang Le,Jani Vihasi,Cheng Ying,Zhang Zhiwen,Belinskaya Tatyana,Qiu Qi,Long Tran Khanh,Schilling Megan A.,Jenkins Sarah A.,Corson Karen S.,Martin Nicholas J.,Letizia Andrew G.,Hontz Robert D.,Sun Peifang
Abstract
Vaccination with the primary two-dose series of SARS-CoV-2 mRNA protects against infection with the ancestral strain, and limits the presentation of severe disease after re-infection by multiple variants of concern (VOC), including Omicron, despite the lack of a strong neutralizing response to these variants. We compared antibody responses in serum samples collected from mRNA-1273 (Moderna) vaccinated subjects to identify mechanisms of immune escape and cross-protection. Using pseudovirus constructs containing domain-specific amino acid changes representative of Omicron BA.1, combined with domain competition and RBD-antibody depletion, we showed that RBD antibodies were primarily responsible for virus neutralization and variant escape. Antibodies to NTD played a less significant role in antibody neutralization but acted along with RBD to enhance neutralization. S2 of Omicron BA.1 had no impact on neutralization escape, suggesting it is a less critical domain for antibody neutralization; however, it was as capable as S1 at eliciting IgG3 responses and NK-cell mediated, antibody-dependent cell cytotoxicity (ADCC). Antibody neutralization and ADCC activities to RBD, NTD, and S1 were all prone to BA.1 escape. In contrast, ADCC activities to S2 resisted BA.1 escape. In conclusion, S2 antibodies showed potent ADCC function and resisted Omicron BA.1 escape, suggesting that S2 contributes to cross-protection against Omicron BA.1. In line with its conserved nature, S2 may hold promise as a vaccine target against future variants of SARS-CoV-2.
Subject
Immunology,Immunology and Allergy
Reference69 articles.
1. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein;Walls;Cell,2020
2. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens;Duan;Front Immunol,2020
3. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination;Sternberg;Life Sci,2020
4. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation;Wrapp;Science,2020
5. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial;Gilbert;Science,2022